Modified Müller's Muscle-conjunctival Resection Internal Ptosis Repair Using Fibrin Glue

Sponsor
Sheba Medical Center (Other)
Overall Status
Unknown status
CT.gov ID
NCT03392272
Collaborator
(none)
50
1
2
24
2.1

Study Details

Study Description

Brief Summary

Fibrin glue is widely used in ophthalmology for homeostasis and tissue recovery. It is commonly used in ocular surface surgeries such as pterygium removal and conjunctival lesions excisions. In Müller's muscle-conjunctival resection (MMCR), sutures are used to reconnect the conjunctiva and Muller muscle, which causes discomfort and pain for the patient. The investigators' goal is to explore using fibrin glue instead of sutures in MMCR surgeries to shorten the procedure's length and alleviate patients discomfort and pain. This is especially important in the management of children suffering ptosis, where sedation and even general anaesthesia is required for sutured removal as a secondary procedure.

Condition or Disease Intervention/Treatment Phase
  • Device: Using of Tisseel fibrin glue
  • Other: Using sutures
N/A

Detailed Description

Fibrin glue is widely used in ophthalmology for homeostasis and tissue recovery. It is commonly used in ocular surface surgeries such as pterygium removal and conjunctival lesions excisions.

Müller's muscle-conjunctival resection (MMCR) is the most common surgery for ptosis correction and is normally performed under local anaesthesia. In MMCR, a portion of the Muller and conjunctiva is resected, and sutures are used to reconnect the remaining edges. The suturing process requires several minutes and causes discomfort to the patient. In addition, many patients experience post operative discomfort due to the touch of the sutures in the superior ocular surface until their removal about 7-14 days post op. Moreover, the sutures removal process is commonly unpleasant, and in the pediatric patients requires sedation or general anaesthesia.

The investigators' goal is to explore using fibrin glue instead of sutures in MMCR surgeries to shorten the procedure's length and alleviate patients discomfort and pain. This is especially important in the management of children suffering ptosis, where sedation and even general anaesthesia is required for sutured removal as a secondary procedure.

Methods:

A prospective randomized study. Patients will be randomized into traditional MMCR using sutures, vs. MMCR using tisseel glue. Follow up will take place 1 day, 7 days, 1 month and 3 months post op. Main outcome measures included patient reported outcome such as pain grade and discomfort, and success of ptosis repair surgery defined by improvement in margin reflex distance, symmetry of upper eyelid position, and incidence of complications.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
50 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
A prospective randomized studyA prospective randomized study
Masking:
Single (Care Provider)
Masking Description:
The physician will randomly assign the patient into the tisseel group or the sutures group
Primary Purpose:
Treatment
Official Title:
Modified Müller's Muscle-conjunctival Resection Internal Ptosis Repair Using Fibrin Glue
Anticipated Study Start Date :
Feb 1, 2018
Anticipated Primary Completion Date :
Feb 1, 2020
Anticipated Study Completion Date :
Feb 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Tisseel

Müller's Muscle-Conjunctival Resection (MMCR) using glue instead of sutures

Device: Using of Tisseel fibrin glue
Using of Tisseel fibrin glue instead of sutures in Müller's Muscle-Conjunctival Resection (MMCR) surgeries

Active Comparator: Sutures

Müller's Muscle-Conjunctival Resection (MMCR) using the usual procedure

Other: Using sutures
Using sutures in Müller's Muscle-Conjunctival Resection (MMCR) surgeries

Outcome Measures

Primary Outcome Measures

  1. Pain level [until 2 weeks post op]

    Pain grade using visual analogue scale of 0-10 with 0=no pain and 10=worst pain.

Secondary Outcome Measures

  1. successful ptosis correction [3 months]

    satisfying improvement of margin to reflex distance

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

Patients with ptosis referred to Müller's Muscle-Conjunctival Resection (MMCR)

Exclusion Criteria:

Previous eyelid surgery

Contacts and Locations

Locations

Site City State Country Postal Code
1 Sheba_Medical_Center Ramat Gan Israel 52621

Sponsors and Collaborators

  • Sheba Medical Center

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Dr. Guy Ben-Simon, MD, Head, oculoplastic unit, Sheba Medical Center
ClinicalTrials.gov Identifier:
NCT03392272
Other Study ID Numbers:
  • SHEBA-17-4383-GBS
First Posted:
Jan 5, 2018
Last Update Posted:
Jan 5, 2018
Last Verified:
Jan 1, 2018
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
Yes
Keywords provided by Dr. Guy Ben-Simon, MD, Head, oculoplastic unit, Sheba Medical Center
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 5, 2018